Incretin Atlas › Molecules › Danuglipron
Danuglipron
GLP-1 (small molecule) · oral · Pfizer
Summary
- Also known as
- PF-06882961, Pfizer
- Mechanism
- GLP-1 (small molecule)
- Route
- oral
- Company
- Pfizer
- Highest development stage
- stopped
- Status (as of data cut)
- Discontinued (2025, liver safety signal) verify
- Next milestone
- —
Trial arms: weight, HbA1c and tolerability
No trial arms with extracted efficacy or tolerability data yet.
Primary sources
No source recorded.
How to cite this page
Medical Adviser's Group. Incretin Atlas: Danuglipron. Data cut 12 November 2026. https://docs.mdwrt.app/infographics/incretin-atlas/danuglipron/ Data: doi:10.5281/zenodo.23473913. Accessed 16 November 2026.
Cite the primary publication for any single result; every value above links to it.